Advertisement

TransCode Therapeutics, Inc. RNAZ

Set alert

Price alert · RNAZ

All alert types
1.63 USD -0.10 -5.78%

At close

1.60 -0.03 -1.84%

Pre-market · Nov 2, 7:00 AM ET

Bid
1.61 × 2
Ask
1.69 × 1
1.63 Day range 1.79
1.52 52-week range 12.60
YTD
-76.13%
1 year
-85.11%
Open
1.73
Prev close
1.73
Mkt cap
27.60M
Vol
16.18K
Avg vol
53.82K
EPS
-52.06
P/E
0.00
Div yield
0.00%
More statistics
Low
1.63
High
1.79
Forward P/E
-5.97
Beta
0.65
Short ratio
0.50
Inst. own
1.99%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
13.50
200-d avg
20.41
1y target
20.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for RNAZ has not been loaded yet. Try again in a moment.

Ownership

Held by insiders 0.01%
Held by institutions 1.99%
Float held by institutions 1.99%
Institutions 11

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Geode Capital Management, LLC0.53%3,69013.21KSep 29, 2024
Private Capital Management LLC0.35%2,4458.75KSep 29, 2024
Sheets Smith Wealth Management0.22%1,5195.44KSep 29, 2024
Jane Street Group, LLC0.17%1,2044.31KSep 29, 2024
Captrust Financial Advisors0.07%4921.76KSep 29, 2024
Morgan Stanley0.04%3031.08KSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.42%2,90610.40KOct 30, 2024
Fidelity Total Market Index Fund0.17%1,1804.22KOct 30, 2024
Fidelity Series Total Market Index Fund0.10%6862.46KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.00%33118Oct 30, 2024
RNAZ insiders
InsiderRelationLatest transactionDateShares held
DUDLEY ROBERT MICHAELChief Executive OfficerPurchaseSep 27, 2023180,262
FITZGERALD THOMAS AChief Financial OfficerPurchaseSep 27, 202356,318

Held by funds

1 US ETFs and mutual funds hold RNAZ · largest positions

Funds holding RNAZ, by value held
FundValue heldWeight in fund
VEXAX $11.00K0.00%
Advertisement